全文获取类型
收费全文 | 304篇 |
免费 | 17篇 |
专业分类
321篇 |
出版年
2019年 | 1篇 |
2018年 | 4篇 |
2017年 | 2篇 |
2016年 | 6篇 |
2015年 | 14篇 |
2014年 | 15篇 |
2013年 | 23篇 |
2012年 | 13篇 |
2011年 | 14篇 |
2010年 | 24篇 |
2009年 | 24篇 |
2008年 | 13篇 |
2007年 | 12篇 |
2006年 | 11篇 |
2005年 | 13篇 |
2004年 | 11篇 |
2003年 | 3篇 |
2002年 | 5篇 |
2001年 | 6篇 |
2000年 | 4篇 |
1999年 | 3篇 |
1998年 | 9篇 |
1997年 | 10篇 |
1996年 | 4篇 |
1995年 | 6篇 |
1994年 | 3篇 |
1993年 | 7篇 |
1991年 | 3篇 |
1989年 | 2篇 |
1988年 | 7篇 |
1986年 | 1篇 |
1985年 | 4篇 |
1984年 | 4篇 |
1983年 | 3篇 |
1982年 | 16篇 |
1981年 | 3篇 |
1980年 | 1篇 |
1979年 | 2篇 |
1978年 | 2篇 |
1977年 | 5篇 |
1976年 | 3篇 |
1975年 | 3篇 |
1972年 | 1篇 |
1971年 | 1篇 |
排序方式: 共有321条查询结果,搜索用时 15 毫秒
241.
242.
Lymphocyte locomotion and attachment on two-dimensional surfaces and in three-dimensional matrices 总被引:6,自引:3,他引:6 下载免费PDF全文
The adhesion and locomotion of mouse peripheral lymph node lymphocytes on 2-D protein- coated substrata and in 3-D matrices were compared. Lymphocytes did not adhere to, or migrate on, 2-D substrata suck as serum- or fibronectin-coated glass. They did attach to and migrate in hydrated 3-D collagen lattices. When the collagen was dehydrated to form a 2-D surface, lymphocyte attachment to it was reduced. We propose that lymphocytes, which are poorly adhesive, are able to attach to and migrate in 3-D matrices by a nonadhesive mechanism such as the extension and expansion of pseudopodia through gaps in the matrix, which could provide purchase for movement in the absence of discrete intermolecular adhesions. This was supported by studies using serum-coated micropore filters, since lymphocytes attached to and migrated into filters with pore sizes large enough (3 or 8 mum) to allow pseudopod penetration but did not attach to filters made of an identical material (cellulose esters) but of narrow pore size (0.22 or 0.45 mum). Cinematographic studies of lymphocyte locomotion in collagen gels were also consistent with the above hypothesis, since lymphocytes showed a more variable morphology than is typically seen on plane surfaces, with formation of many small pseudopodia expanded to give a marked constriction between the cell and the pseudopod. These extensions often remained fixed with respect to the environment as the lymphocyte moved away from or past them. This suggests that the pseudopodia were inserted into gaps in the gel matrix and acted as anchorage points for locomotion. 相似文献
243.
244.
Dimitrios Makrygiannakis Shankar Revu Marianne Engström Erik af Klint Anthony P Nicholas Ger JM Pruijn Anca I Catrina 《Arthritis research & therapy》2012,14(1):R20-9
Introduction
Protein citrullination is present in the rheumatoid synovium, presumably contributing to the perpetuation of chronic inflammation, in the presence of specific autoimmunity. As a result, the present study examined the possibility that effective antirheumatic treatment will decrease the level of synovial citrullination.Methods
Synovial biopsies were obtained from 11 rheumatoid arthritis (RA) patients before and after 8 weeks of treatment with 20 mg methotrexate weekly, 15 RA patients before and 2 weeks after an intraarticular glucocorticoid injection, and eight healthy volunteers. Synovial inflammation was assessed with double-blind semiquantitative analysis of lining thickness, cell infiltration, and vascularity by using a 4-point scale. Expression of citrullinated proteins (CPs) with the monoclonal antibody F95 and peptidylarginine deiminase (PAD) 2 and 4 was assessed immunohistochemically with double-blind semiquantitative analysis. In vitro synovial fluid (SF), peripheral blood (PB), mononuclear cells (MCs), and synovial explants obtained from RA patients were incubated with dexamethasone and analyzed with immunohistochemistry for expression of CP as well as PAD2 and PAD4 enzymes.Results
The presence of synovial CP was almost exclusive in RA compared with healthy synovium and correlated with the degree of local inflammation. Treatment with glucocorticoids but not methotrexate alters expression of synovial CP and PAD enzymes, in parallel with a decrease of synovial inflammation. Ex vivo and in vitro studies suggest also a direct effect of glucocorticoids on citrullination, as demonstrated by the decrease in the level of citrullination and PAD expression after incubation of SFMC and synovial explants with dexamethasone.Conclusion
Synovial citrullination and PAD expression are dependent on local inflammation and targeted by glucocorticoids. 相似文献245.
The presence or absence of antibodies to citrullinated peptides/proteins (ACPA) is an important parameter that helps a clinician
set a diagnosis of early rheumatoid arthritis and, hence, initiate treatment. There are several commercial tests available
to measure ACPA levels, although it can be difficult to decide what the best test for a given clinical question is. We analyzed
literature data in which the diagnostic and other properties of various ACPA tests are compared. The results show that for
diagnostic purposes the CCP2 test has the highest specificity, the highest sensitivity in stratified studies and the highest
positive predictive value. For the prediction of future joint destruction the CCP2, MCV, and CCP3 tests may be used. The ability
to predict the likelihood of not achieving sustained disease-modifying antirheumatic drug-free remission was highest for the
CCP2 test. Finally, the levels of anti-CCP2 and anti-CCP3 (and possibly anti-mutated citrullinated vimentin) in rheumatoid
arthritis patients are not significantly influenced by TNFα blocking agents. 相似文献
246.
Evolution of the secondary structures and compensatory mutations of the ribosomal RNAs of Drosophila melanogaster 总被引:10,自引:0,他引:10
This paper examines the effects of DNA sequence evolution on RNA secondary
structures and compensatory mutations. Models of the secondary structures
of Drosophila melanogaster 18S ribosomal RNA (rRNA) and of the complex
between 2S, 5.8S, and 28S rRNAs have been drawn on the basis of comparative
and energetic criteria. The overall AU richness of the D. melanogaster
rRNAs allows the resolution of some ambiguities in the structures of both
large rRNAs. Comparison of the sequence of expansion segment V2 in D.
melanogaster 18S rRNA with the same region in three other Drosophila
species and the tsetse fly (Glossina morsitans morsitans) allows us to
distinguish between two models for the secondary structure of this region.
The secondary structures of the expansion segments of D. melanogaster 28S
rRNA conform to a general pattern for all eukaryotes, despite having highly
divergent sequences between D. melanogaster and vertebrates. The 70 novel
compensatory mutations identified in the 28S rRNA show a strong (70%) bias
toward A-U base pairs, suggesting that a process of biased mutation and/or
biased fixation of A and T point mutations or AT-rich slippage-generated
motifs has occurred during the evolution of D. melanogaster rDNA. This
process has not occurred throughout the D. melanogaster genome. The
processes by which compensatory pairs of mutations are generated and spread
are discussed, and a model is suggested by which a second mutation is more
likely to occur in a unit with a first mutation as such a unit begins to
spread through the family and concomitantly through the population.
Alternatively, mechanisms of proofreading in stem-loop structures at the
DNA level, or between RNA and DNA, might be involved. The apparent
tolerance of noncompensatory mutations in some stems which are otherwise
strongly supported by comparative criteria within D. melanogaster 28S rRNA
must be borne in mind when compensatory mutations are used as a criterion
in secondary-structure modeling. Noncompensatory mutation may extend to the
production of unstable structures where a stem is stabilized by RNA-
protein or additional RNA-RNA interactions in the mature ribosome. Of
motifs suggested to be involved in rRNA processing, one (CGAAAG) is
strongly overrepresented in the 28S rRNA sequence. The data are discussed
both in the context of the forces involved with the evolution of multigene
families and in the context of molecular coevolution in the rDNA family in
particular.
相似文献
247.
Although invertebrate drift is an important ecological process in lotic ecosystems, very little is known about it in Kenyan rivers. The primary aim of this study was to investigate the effect of driftnet mesh size and exposure duration on drift density in 2017. Drift samples were dominated by Chironomidae, Baetidae, Simuliidae, Caenidae and Culicidae. The 100 µm mesh driftnet had the highest mean invertebrate density, followed by the 250 µm and 500 µm nets. Invertebrate drift densities decreased with increased exposure time. This study demonstrates that sampler mesh size and exposure time should be taken into account when characterising invertebrate drift in streams. Future studies should consider sampling different biotopes and during different seasons. 相似文献
248.
249.
Valerie R Wiersma Marco de Bruyn Ce Shi Marloes JM Gooden Maartje CA Wouters Douwe F Samplonius Djoke Hendriks Hans W Nijman Yunwei Wei Jin Zhou Wijnand Helfrich Edwin Bremer 《MABS-AUSTIN》2015,7(2):321-330
The therapeutic effect of anti-cancer monoclonal antibodies stems from their capacity to opsonize targeted cancer cells with subsequent phagocytic removal, induction of antibody-dependent cell-mediated cytotoxicity (ADCC) or induction of complement-mediated cytotoxicity (CDC). The major immune effector cells involved in these processes are natural killer (NK) cells and granulocytes. The latter and most prevalent blood cell population contributes to phagocytosis, but is not effective in inducing ADCC. Here, we report that targeted delivery of the tumoricidal protein tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to granulocyte marker C-type lectin-like molecule-1 (CLL1), using fusion protein CLL1:TRAIL, equips granulocytes with high levels of TRAIL. Upon CLL1-selective binding of this fusion protein, granulocytes acquire additional TRAIL-mediated cytotoxic activity that, importantly, potentiates antibody-mediated cytotoxicity of clinically used therapeutic antibodies (e.g., rituximab, cetuximab). Thus, CLL1:TRAIL could be used as an adjuvant to optimize the clinical potential of anticancer antibody therapy by augmenting tumoricidal activity of granulocytes. 相似文献
250.
Davide?Baú Alberto?JM?Martin Catherine?Mooney Alessandro?Vullo Ian?Walsh Gianluca?PollastriEmail author 《BMC bioinformatics》2006,7(1):402